Explain monoclonal antibody production
WHAT is a monoclonal antibody?
WHY do we need the fusion trick?
| Cell | Makes desired antibody? | Divides forever? |
|---|---|---|
| B-lymphocyte | ✅ yes | ❌ dies in ~days |
| Myeloma cell | ❌ no | ✅ immortal |
| Hybridoma | ✅ yes | ✅ yes |
So neither parent alone works. The hybridoma inherits the best of both.
HOW is it made — step by step (derive the logic)
Step 1 — Immunise. Inject a mouse with the target antigen. Why this step? This triggers the mouse's immune system to produce B-cells already making antibodies against that antigen. We harvest these B-cells from the spleen.
Step 2 — Get myeloma cells. Culture myeloma (cancerous B-cells). Why this step? We need the "immortality gene package." These specially chosen myeloma cells are also HGPRT⁻ (lack the enzyme HGPRT) — this becomes crucial for selection in Step 4.
Step 3 — Fuse. Mix spleen B-cells + myeloma cells with a fusion agent (PEG, polyethylene glycol — it melts membranes together). Why this step? Fusion physically merges two cells into one hybrid = hybridoma. But fusion is random, so the dish now contains: unfused B-cells, unfused myeloma, and hybridomas. We must remove the first two.
Step 4 — Select in HAT medium. Grow everything in HAT medium (Hypoxanthine–Aminopterin–Thymidine). Why this step? (the clever bit)
- Cells make DNA by two routes: the de novo pathway and the salvage pathway.
- Aminopterin BLOCKS the de novo pathway. So a cell can only survive by using the salvage pathway, which needs the enzyme HGPRT.
- Unfused myeloma cells are HGPRT⁻ → salvage blocked → die. ✅
- Unfused B-cells are normal but mortal → die in a few days anyway. ✅
- Hybridomas get HGPRT from the B-cell parent AND immortality from the myeloma parent → survive & divide. ✅ So HAT medium is a filter that leaves only hybridomas.
Step 5 — Screen & clone. Test hybridoma cultures to find the one making the antibody you actually want, then dilute so each well grows from a single cell (=one clone). Why this step? Different hybridomas make different antibodies. We need the clone against one specific epitope — that's what makes it monoclonal.
Step 6 — Mass-produce. Grow the chosen clone in large bioreactors (in vitro) or as ascites in mice (in vivo). Purify the antibody. Why this step? One immortal clone → unlimited identical antibodies.
Uses (WHY it matters — the 80/20)
Common mistakes
Recall Feynman: explain to a 12-year-old
Imagine you want a factory that stamps out ONE exact shape of key. You have a worker who knows the exact shape but gets tired and quits (the B-cell). You have a robot that never stops but doesn't know the shape (the cancer cell). So you glue the worker onto the robot — now the robot-worker knows the shape and never stops. That glued combo is a hybridoma, and it makes the same key forever. We then throw away everyone except this combo by putting them in a special food (HAT) only the combo can eat.
Flashcards
What is a monoclonal antibody?
What is a hybridoma?
Why can't a B-lymphocyte alone be used to mass-produce mAbs?
Why can't a myeloma cell alone be used?
What fusing agent merges the cells?
Where are the antibody-producing B-cells obtained from?
What does HAT stand for?
In HAT medium, what does aminopterin do?
Which enzyme lets cells survive via the salvage pathway?
Why do unfused myeloma cells die in HAT?
Why do unfused B-cells die in HAT?
Why do hybridomas survive HAT?
Difference between monoclonal and polyclonal antibodies?
Give two uses of monoclonal antibodies.
Connections
- Antibody Structure and Epitopes
- Cell Culture and Bioreactors
- Cancer and Myeloma Cells
- ELISA and Diagnostic Kits
- Immune Response - B and T cells
- Recombinant Therapeutics
Concept Map
Hinglish (regional understanding)
Intuition Hinglish mein samjho
Dekho, body jab kisi germ ko dekhti hai to bahut saare alag-alag antibodies banati hai — yeh polyclonal hota hai. Lekin science mein hume kabhi-kabhi ek hi type ka pure antibody chahiye hota hai jo bilkul ek hi jagah (ek epitope) par chipke. Usi ko monoclonal antibody bolte hain. Problem yeh hai ki jo cell (B-lymphocyte) sahi antibody banata hai woh lab dish mein jaldi mar jaata hai, aur jo cell hamesha zinda rehta hai (myeloma/cancer cell) woh antibody nahi banata.
Toh trick simple hai: dono cells ko PEG se jod do — ab jo hybrid banega usko naam mila hybridoma. Ismein B-cell wali antibody-banane ki power bhi hai aur myeloma wali "kabhi na marna" wali immortality bhi. Best of both!
Ab fusion random hota hai, toh dish mein kuch unfused B-cells, kuch unfused myeloma, aur kuch hybridomas honge. Inko alag karne ke liye HAT medium use karte hain. Isme aminopterin de novo DNA banane ka main raasta band kar deta hai, toh cell ko HGPRT enzyme wala salvage raasta use karna padta hai. Myeloma HGPRT⁻ hai (mar jaata hai), B-cell waise hi mortal hai (mar jaata hai), sirf hybridoma dono cheez rakhta hai — toh sirf wahi zinda bachta hai. Yaad rakho: HAT cancer ko target nahi karta, yeh metabolic filter hai.
Aakhir mein us hybridoma ko screen karke, single cell se clone banake, bioreactor mein grow karke unlimited pure antibodies bana lete hain. Yeh matter isliye karta hai kyunki inhi mAbs se pregnancy kits, COVID rapid tests, aur cancer ki targeted therapy (jaise Trastuzumab) banti hai — ek hi target par lock, healthy cells safe.